Brief: Medexus Expands Its US Product Portfolio By Acquiring The Hematology Asset Ixinity

Medexus Pharmaceuticals

28/02/2020 14:05

Feb 28 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS EXPANDS ITS US PRODUCT PORTFOLIO BY ACQUIRING THE
HEMATOLOGY ASSET IXINITY®
    * MEDEXUS PHARMACEUTICALS INC - ANNOUNCES US$20 MILLION
CREDIT
FACILITY WITH MIDCAP FINANCIAL
    * MEDEXUS PHARMACEUTICALS INC - ACQUISITION EXPECTED TO BE
IMMEDIATELY ACCRETIVE TO ADJUSTED EBITDA
    * MEDEXUS PHARMACEUTICALS INC - DEAL FOR UP-FRONT CASH
CONSIDERATION OF APPROXIMATELY US$30 MILLION
    * MEDEXUS PHARMACEUTICALS - DEAL FINANCED ENTIRELY WITH
EXISTING
CASH, NEW US$20 MILLION TERM LOAN CREDIT FACILITY WITH MIDCAP
FINANCIAL

Source text for Eikon:  ID:nGNX4Sc9ry 
Further company coverage:  MDP.V 

 ((Reuters.Briefs@thomsonreuters.com;))